Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Oftalmología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination With Aflibercept, Compared With Aflibercept Alone, in Participants With nAMD
INTERVENTIONAL
Inicio: 12 de mar de 2021
ID: NCT04757636
Completado
Fase 3
ClinicalTrials.gov
A Two-year, Three-arm, Randomized, Double-masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Adult Patients With Visual Impairment Due to Diabetic Macular Edema
INTERVENTIONAL
Inicio: 23 de jul de 2018
ID: NCT03481634
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination With Ranibizumab, Compared With Ranibizumab Alone, in Participants With nAMD
INTERVENTIONAL
Inicio: 12 de mar de 2021
ID: NCT04757610
Activo, no recluta
RENIS
Evaluación de la duración del efecto de Bimatoprost SR en participantes con glaucoma de ángulo abierto o hipertensión ocular
INTERVENTIONAL
ID: IS003768
Reclutando
RENIS
Estudio clínico fase III, para evaluar la no inferioridad en la disminución de la presión intraocular de la solución oftálmica PRO-122 libre de conservadores, elaborada por Laboratorios Sophia S.A. de C.V., versus terapia concomitante, en sujetos con glaucoma primario de ángulo abierto y/o hipertens
INTERVENTIONAL
ID: IS002598
Completado
RENIS
UN ESTUDIO SOBRE LA SEGURIDAD Y EFICACIA A LARGO PLAZO DE ADALIMUMAB EN SUJETOS CON UVEITIS INTERMEDIA, UVEITIS POSTERIOR O PANUVEITIS. VISUAL III
INTERVENTIONAL
ID: IS000313
Completado
Fase 4
ClinicalTrials.gov
Patient Preference Comparison of AZARGA Versus COSOPT After Single Doses in Patients With Open-Angled Glaucoma or Ocular Hypertension
INTERVENTIONAL
Inicio: 1 de sept de 2010
ID: NCT01471158
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Active, Non-Infectious Intermediate-, Posterior-, and Panuveitis
INTERVENTIONAL
Inicio: 11 de sept de 2024
ID: NCT06431373
Completado
Fase 4
ClinicalTrials.gov
Multicentric Study to Evaluate the Efficacy and Tolerability of an Innovative Formulation of Benzalkonium Chloride-free Latanoprost in Patients With Primary Open-Angle Glaucoma
INTERVENTIONAL
Inicio: 6 de ene de 2017
ID: NCT03331770
Completado
Fase 3
ClinicalTrials.gov
An Open-label Extension (OLE) Phase 3 Trial to Assess the Safety of Intravitreal Administration of Avacincaptad Pegol (Complement C5 Inhibitor) in Patients With Geographic Atrophy Who Previously Completed Phase 3 Study ISEE2008 (GATHER2)
INTERVENTIONAL
Inicio: 26 de sept de 2022
ID: NCT05536297
Completado
ClinicalTrials.gov
A Prospective Observational Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America
OBSERVATIONAL
Inicio: 28 de mar de 2018
ID: NCT03470103
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Double-Masked, Randomized, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)
INTERVENTIONAL
Inicio: 29 de ene de 2024
ID: NCT06223958
Activo, no recluta
ClinicalTrials.gov
Real-World, Long-Term Data Collection to Gain Clinical Insights Into Roche Ophthalmology Products (VOYAGER STUDY)
OBSERVATIONAL
Inicio: 21 de nov de 2022
ID: NCT05476926
Terminado
Fase 3
ClinicalTrials.gov
A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects With Neovascular Age-Related Macular Degeneration (AMD) (PANDA-1)
INTERVENTIONAL
Inicio: 25 de sept de 2018
ID: NCT03577899
Reclutando
ClinicalTrials.gov
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
OBSERVATIONAL
Inicio: 12 de may de 2025
ID: NCT06924021
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Double-Masked, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration
INTERVENTIONAL
Inicio: 27 de nov de 2024
ID: NCT06495918
Completado
Fase 3
ClinicalTrials.gov
A 96-week, Two-arm, Randomized, Single-masked, Multi-center, Phase III Study Assessing the Efficacy and Safety of Brolucizumab 6 mg Compared to Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy
INTERVENTIONAL
Inicio: 19 de nov de 2020
ID: NCT04278417
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase IIIb, Global, Multicenter, Randomized, Visual Assessor-Masked Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)
INTERVENTIONAL
Inicio: 14 de jul de 2021
ID: NCT04657289
Completado
Fase 3
ClinicalTrials.gov
A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
INTERVENTIONAL
Inicio: 28 de feb de 2019
ID: NCT03850782
Reclutando
Fase 3
ClinicalTrials.gov
A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Portal)
INTERVENTIONAL
Inicio: 20 de sept de 2018
ID: NCT03683251
1
2
...
434
Siguiente
Filtros